Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China

TORONTO and SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF) today announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in theGreater China region. Nuance is a biopharmaceutical company focused on licensing, developing and com...

2021-02-09 20:00 5103

Guide IR Ranks Top 2 in Yole Report as Global Infrared Thermal Imaging Market Explodes

WUHAN, China, Feb. 9, 2021 /PRNewswire/ -- Yole Développement, the internationally renowned market survey and strategic consulting firm, has launched its latest industry analysis entitled Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary Report. The report reveals that ...

2021-02-09 19:26 2259

MDBriefCase Establishes World-Class Oncology Scientific Steering Committee

Leading global oncology professionals to identify areas of opportunity for educational programs worldwide TORONTO, Feb. 9, 2021 /PRNewswire/ -- MDBriefCase Group Inc. ("MDBriefCase"), a global provider of leading online continuing medical education and professional development for healthcare pro...

2021-02-09 19:00 906

Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China

SHENZHEN, China, Feb. 9, 2021 /PRNewswire/ -- Aesthetic Medical International Holdings Group Limited (the "Company" or "AIH", Nasdaq: AIH), a leading provider of aesthetic medical services inChina, and Forbes China have jointly releasedthe Chinese Aesthetic Treatment Industry White Paper 2020 (t...

2021-02-09 18:00 2452

Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter

STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...

2021-02-09 16:30 1555

Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant

SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- On February 7, 2021, scientists from Jemincare Shanghai Research Institute published a preprint paper on BioRxiv, the paper entitled "A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prop...

2021-02-09 11:18 1282

Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant

Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China

SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Yingli Pharma announced today that it reached strategic collaboration with Hengrui Medicine (600276.SH), a partnership which will significantly accelerate the expansion of Yingli Pharma's oncology business inChina, the second largest pharmaceutical market in...

2021-02-09 08:30 1538

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics

* Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiate any project within four weeks * Offer flexible large-scale manufacturing services by implementing Scale-out strategy WUXI, China, Feb. 9, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.H...

2021-02-09 08:25 1846

Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma

SAN FRANCISCO and SUZHOU, China, Feb. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2021-02-09 08:00 7875

Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development

RENO, Nev., Feb. 9, 2021 /PRNewswire/ -- Bioelectronica Corporation ("Bioelectronica") today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The ...

2021-02-09 04:46 2519

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan experts present strategic insights on key trends such as virtual care, vaccines, hospital efficiency solutions, digital biomarkers, and microbiome therapeutics SANTA CLARA, Calif., Feb. 9, 2021 /PRNewswire/ -- Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving b...

2021-02-09 01:43 249

Peloton Interactive, Inc. Announces Proposed Private Offering of $600.0 Million of Convertible Senior Notes Due 2026

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Peloton Interactive, Inc. ("Peloton") (Nasdaq: PTON) today announced its intention to offer, subject to market conditions and other factors,$600.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private offering (th...

2021-02-08 21:47 6976

Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products

Highlights: * Cooperation Agreement with Terumo Blood and Cell Technologies to promote and sell both companies complementary regenerative products inAsia-Pacific. * Terumo Blood and Cell Technologies' products will be used to concentrate a patient's bone marrow and mixed into Osteopore scaffo...

2021-02-08 21:21 1676

Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 8, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...

2021-02-08 21:00 7334

Basecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF Kit

HONG KONG, Feb. 8, 2021 /PRNewswire/ -- Basecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, today officially listed on the main board of HKEX (HKG: 2170). Approximately 66.667 million shares were issued and total funds raised was...

2021-02-08 19:32 4588

Basecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF Kit

CareCapital appoints Bindusaran as Executive Director

HONG KONG, Feb. 8, 2021 /PRNewswire/ -- CareCapital Advisors Limited ("CareCapital") announces the appointment of Mr. A P A Bindusaran as Executive Director and Head of DSO Clinical and Business Development. Prior to joining CareCapital, Mr. Bindusaran spent 16 years in R&D, clinical affairs, tre...

2021-02-08 18:14 1454

Inova Appoints Claude Basset as Chief Product Officer

LYON, France, Feb. 8, 2021 /PRNewswire/ -- Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude Basset has joined their leadership team as Chief Product Officer. Inova is a French Tech success story that, now in its 10th year, ha...

2021-02-08 16:00 1251

Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)

First Patient to Receive ORL-101 in Israel This Week BAAR, Switzerland, Feb. 8, 2021 /PRNewswire/ -- Orpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a novel ...

2021-02-08 15:00 1652

Zamst announces sponsorship with Yuji Nishida, Professional Volleyball Player

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., owner of Zamst, a brand of athletic braces and care products headquartered inTokyo, Japan, has entered a sports sponsorship agreement withYuji Nishida, Japanese men's professional volleyball player for JTEKT Stings in V.League.

2021-02-08 14:00 4693

Zamst announces sponsorship with Yuji Nishida, Professional Volleyball Player

AXA launches "Wealth Ultra Savings Plan (2-year Pay)"

HONG KONG, Feb. 8, 2021 /PRNewswire/ -- AXA Hong Kong and Macau today announced the launch of "Wealth Ultra Savings Plan (2-year Pay)"("Wealth Ultra (2-year Pay)"), a participating life insurance plan with a short premium payment term of two years. Customers can enjoy sustainable wealth growth wi...

2021-02-08 13:55 2180

1 ... 559 560 561562563 564 565 ... 808